ClinicalTrials.gg
RecruitingNCT06776003VOPE2 COMPASUpdated Jun 25, 2025

Continuous Mobility and Physical Activity in Vertebroplasty vs Sham for Osteoporotic Vertebral Fracture

An interventional study of Vertebroplasty and Sham Vertebroplasty in Osteoporotic Vertebral Compression Fractures, sponsored by Spine Centre of Southern Denmark. Recruiting at 1 site in Denmark. Open to participants aged 50 Years and older. Per ClinicalTrials.gov, last updated 2025-06-25.

Primary conditionMotor Activity(the registry's first term)UnverifiedIs this wrong?Motor Activity is a broad heading, used only when no more specific condition is named. No better condition is named, so the registry's term is kept.

Sponsored by Spine Centre of Southern Denmark · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Feb 2025; still recruiting 1 year 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
64
Allocation
Randomized
Ages
50 Years and older
Sex
All
01

Study summary

The aim of this clinical trial is to determine if vertebroplasty is an effective treatment for acute, painful vertebral fractures due to osteoporosis.

The focus of the study is on the physical activity and mobility of participants.

The main questions the trial aims to answer are:

  • Does vertebroplasty lead to increased physical activity as measured by accelerometer?
  • Does vertebroplasty lead to increased mobility as measured by GPS (global positioning system)?
  • Do physical activity and mobility correlate with pain, disability and quality of life?

Researchers will compare vertebroplasty to sham (simulated surgery without active intervention) to understand if vertebroplasty improves physical activity and mobility.

Participants will

  • Undergo vertebroplasty or sham procedure
  • Wear an accelerometer and a GPS-reciever in a belt for 1 week before to 4 weeks after the surgery
  • Answer questionnaires regarding pain, disability and quality of life at regular intervals.

The knowledge gained from this can help determine who would benefit from vertebroplasty.

Read the detailed description

Despite attempts at prevention, osteoporotic vertebral fracture occurs with increasing frequency as lifespans increase.

Patients with this disease can experience severe pain and disability, and when conservative treatment is inadequate, vertebroplasty is an option.

In this surgical procedure, polymethyl metacrylate, or "bone cement" is injected into the fractured vertebral body. However, the procedure is currently controversial for the treatment of osteoporotic vertebral fractures because there is not yet consensus on the efficacy.

By investigating the effect of vertebroplasty on mobility and physical activity, this study aims to contribute to resolution of the controversy.

The study is a prospective, double-blind, randomized, sham-controlled clinical trial, where participants will be randomized to either vertebroplasty or a sham operation.

The study is embedded in the ongoing trial "Percutaneous Vertebroplasty Vs. Sham for Osteoporotic Vertebral Compression Fractures Focusing on Pain and Economy (VOPE2)" with ClinicalTrials.gov ID NCT06141187.

A subset of the participants in VOPE2 will, in addition to previously planned activities, be equipped with wearable accelerometers and a global positioning system (GPS).

The trial is designed in accordance with the SPIRIT guidelines.

Potential participants will be identified by referral to the Center for Spine Surgery and Research from general practitioners, chiropractor, physiotherapist, or from hospital inpatient and emergency departments in the region of Southern Denmark.

Participants will then be examined in an outpatient clinic by a spine surgeon, and have MRI scans and X-ray images analyzed by experienced neuro-radiologists.

If eligible, they will be offered to participate following informed consent. An accelerometer and GPS-reciever attached to an elastic waist band are initiated following inclusion.

Subjects will initially be stratified into two groups based on the number of OVCFs into 1-2 levels or 3-4 levels.

Within each of these two groups, randomization sheets in varying blocks of 8 with an equal number of PVP and sham patients in each block will be generated using software (www.randomizer.org) and will be placed in numbered, opaque, sealed envelopes.

Treatment group assignment is 1:1 and will be performed by a scrub nurse in the surgical theatre after the patient is draped but prior to skin incision.

Throughout the trial, only the surgeon and the OR-nurse will have knowledge of the treatment assignment.

The patient and all assessors remain blinded to the treatment group throughout the study. Spine surgeons who are experienced in PVP will perform the surgical procedures.

Anaesthesiologists and spine surgeons are present at the facility in case of complications, following recommendations by the National Health Authority and have the capacity/capability to decompress the spinal canal in case of cement leakage

Based on qualitative studies and clinical experience, patients with painful osteoporotic vertebral fractures restrict their movement because of pain.

This in turn leads to reduced physical activity and diminished ability to move oneself around and away from home, defined here as mobility.

If vertebroplasty is effective, it is expected to lead to increased physical activity and mobility compared to sham, and the outcomes derived from accelerometers and GPS-recievers can supplement patient reports due to their continuous and objective nature.

02

Conditions studied

  • Osteoporotic Vertebral Compression Fractures

Browse trials for

Keywords

  • Accelerometer
  • Global Positioning System
  • Vertebroplasty
  • Physical Activity
  • Mobility
  • Osteoporosis
  • Spinal Surgery
  • ActiGraph
  • Accelerometry
  • GPS
  • Osteoporotic
03

In context

Motor Activity Unverified

9,827 studies on the registry are indexed under Motor Activity; 1,911 are open to participants now.

This study's planned enrollment of 64 is close to the median of 60 across 8,412 interventional studies indexed under Motor Activity.

Browse Motor Activity studies →

Lead sponsor

Spine Centre of Southern Denmark is the lead sponsor of 22 studies on the registry; 3 are open to participants now.

Compared within Motor Activity, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
50 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients aged 50+ and diagnosed with symptomatic osteoporotic spinal compression fractures between T6 and L5 (incl).
  • Focal tenderness on the level of the vertebral fracture.
  • Fractures verified with oedema of the relevant vertebra on the MRI STIR sequence.
  • Osteoporotic Fractures type 1-4.
  • Fracture involves no more than 4 vertebral body levels.
  • Vertebroplasty can be done in one session.
  • Back pain score measured on a Visual Analog Scale (VAS, 0 to 100) ≥ 60.
  • Able to understand and read Danish.
  • Written .
  • Relevant pain started ≤ 3 months prior to enrollment.

Exclusion criteria

Exclusion Criteria:

  • for spine surgery.
  • \< 30 mia/l.
  • Osteoporotic Fractures type 5 and Pincer-type.
  • Complete collapse of the vertebral body precluding insertion of needle.
  • Presence of neurologic deficit.
  • Contraindications for MRI scanning.
  • Psychological or psychiatric disorder that is expected to interfere with compliance.
  • Active .
  • (MMSE) test score below 24.
  • History of chronic back pain requiring ongoing opiate use.
  • Systemic or local infection of the spine.
Terms in these criteria, in plain language(5)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

Platelets

Blood cells that help blood clot. Too few raises the risk of bleeding and bruising. A usual adult range is about 150–400 × 10⁹/L (150,000–400,000 per µL); each lab has its own reference range.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
64 participants (estimated)

Study arms

  • Active comparator
    Vertebroplasty

    Polymethyl-methacrylate (PMMA) cement is prepared and injected slowly into the vertebral body under constant bi-plane fluoroscopy Interventions: Procedure: Vertebroplasty

    Procedure: Vertebroplasty

  • Sham comparator
    Sham vertebroplasty

    A short needle is passed through the skin, but not as far as the periosteum. PMMA is mixed to mimic the PVP procedure but not injected into the vertebral body. Interventions: Procedure: Sham Vertebroplasty

    Procedure: Sham Vertebroplasty

Interventions

  • ProcedureVertebroplasty

    Polymethyl-methacrylate (PMMA) cement is injected slowly into the vertebral body under constant bi-plane fluoroscopy

    Also known as: Percutaneous vertebroplasty, PVP

  • ProcedureSham Vertebroplasty

    A short needle is passed through the skin, but not as far as the periosteum. PMMA is mixed to mimic the PVP procedure but not injected into the vertebral body.

06

What researchers measure

Primary outcomes

  1. Change in physical activity before and after intervention

    Physical activity is measured by accelerometer and presented as mean ENMO (euclidian norm minus one) and mean TAC/d (total activity count per day). An unweighted average of valid days within the preoperative week is compared with the unweighted average of valid days within the four postoperative weeks by relative change in percent.

    Time frame: One week preoperatively to the end of the fourth postoperative week.

Secondary outcomes

  1. Daily and weekly physical activity

    Physical activity is measured by accelerometer and presented as difference in mean ENMO (euclidian norm minus one) and mean TAC/d (total activity count per day). Daily means are based on valid wear-time. Weekly means are calculated as unweighted averages of all valid days within the week.

    Time frame: One week preoperatively to 4 weeks postoperatively

  2. Change in daily and weekly physical activity

    Physical activity is measured by accelerometer and presented as difference in mean ENMO (euclidian norm minus one) and mean TAC/d (total activity count per day). Daily means are based on valid wear-time. Weekly means are calculated as unweighted averages of all valid days within the week. This outcome supplements the primary outcome to cover changes within the full study period. Changes are reported as relative percentages.

    Time frame: One week preoperatively to 4 weeks postoperatively

  3. Physical activity levels

    Based on cut-points applied to the ENMO or count measurements, the valid wear-time is divided into intensity classes "sedentary", "light activity" or "moderate to vigorous activity". Time spent in each class is presented as percentage of valid wear-time.

    Time frame: One week preoperatively to 4 weeks postoperatively

  4. Change in physical activity levels

    Based on cut-points applied to the ENMO or count measurements, the valid wear-time is divided into intensity classes "sedentary", "light activity" or "moderate to vigorous activity". Time spent in each class is presented as percentage of valid wear-time and changes as absolute percentage points.

    Time frame: One week preoperatively to 4 weeks postoperatively

  5. Total daily distance and change in total daily distance

    Total daily distance traveled in meters based on GPS positions. Changes are relative in percentages.

    Time frame: One week preoperatively to 4 weeks postoperatively

  6. Time spent stationary and change in time spent stationary

    Percentage of time spent stationary based on GPS positions relative to the days' recording. Change is absolute percentage points.

    Time frame: One week preoperatively to 4 weeks postoperatively

  7. Time spent away from home and change in time spent away from home

    Percentage of time per day where the GPS records a position away from home relative to the days' recordings. Change is in absolute percentage points.

    Time frame: One week preoperatively to 4 weeks postoperatively

  8. Patient-reported pain intensity.

    Pain intensity over the previous 24 hours using the 100-point visual analog scale, where 0 is no pain and 100 is the worst imaginable pain.

    Time frame: VAS will be recorded once preoperatively and again 1, 2, 3, 4 and 5 days + 2 and 4 weeks postoperatively.

  9. Patient-reported disability

    The patients rate their disability using the Oswestry Disability Index (ODI) questionnaire.

    Time frame: Preoperatively and at 4 weeks postoperatively

  10. Patient-reported health-related quality of life.

    Health-related quality of life. on the EuroQol 5-dimension 5-level (EQ-5D-5L)

    Time frame: Preoperatively and at 4 weeks postoperatively

07

Study locations

1 of 1 sites recruiting
  • Spine Centre of Southern Denmark
    Kolding, 6000, Denmark
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Data from questionnaires, accelerometers and GPS-records will be made available in an anonymized form to researchers who present a proposal for the use that is reasonable and can be approved by the study authors.

Supporting information: Study protocol, Statistical analysis plan, Analytic code

Time frame: The IPD and data will be stored for five years from the completetion of the study at the trial site followed by archiving at the Danish National Archives.

Access criteria: Researchers can request access to the information by contacting the investigator via email at soren.wittorff.sorensen@rsyd.dk

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2025 (actual). Primary completion is estimated for Dec 2026, 22 months after the start.

Of 5,176 non-industry interventional studies with no phase under Motor Activity, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 36. This study's planned 22 months is above that.

Counting every sponsor, half of 5,236 studies reached it within 17 months; a quarter within 7 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 9, 2025
First posted
Jan 15, 2025
StartActual
Feb 20, 2025
Primary completionEst.
Dec 2026
CompletionEst.
Dec 2026
Last update
Jun 25, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 25, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06776003
Lead sponsor
Spine Centre of Southern Denmark
Responsible party
Sponsor
First posted
Jan 15, 2025
Start date
Feb 20, 2025
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Jun 25, 2025

Study contacts

Søren W Sørensen, MD
Contact
soren.wittorff.sorensen@rsyd.dk
0045 76362000
Mikkel Ø Andersen, Prof, MD
study chair · Spine Centre of Southern Denmark

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion